[1]
2026. Hybrid Red Blood Cell–Tumor Cell Membrane-Coated Nanoparticles for Cancer Therapy: Biological Principles, Therapeutic Applications, and Translational Challenges. World Journal of Current Medical and Pharmaceutical Research. 8, 2 (Jul. 2026), 88–100. DOI:https://doi.org/10.37022/wjcmpr.v8i2.403.